Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children

Background Next-generation, higher-valency pneumococcal conjugate vaccines (PCVs), 15-valent PCV V114 and 20-valent PCV (PCV20), have been assessed by comparing their immune responses across serotypes shared with the 13-valent PCV (PCV13). Without efficacy or real-world vaccine effectiveness (VE) it...

Cijeli opis

Bibliografski detalji

Glavni autori:	Josiah Ryman, Jeffrey R. Sachs, Ka Lai Yee, Natalie Banniettis, Jessica Weaver, Thomas Weiss
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2024-12-01
Serija:	Expert Review of Vaccines
Teme:	Pneumococcal vaccines Streptococcus pneumoniae child, preschool antibodies, bacterial protective concentration modeling and simulation
Online pristup:	https://www.tandfonline.com/doi/10.1080/14760584.2023.2292773
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!